PERSPECTIVES ON ANALYTICAL RESEARCH AND DEVELOPMENT WITHIN THE PHARMACEUTICAL-INDUSTRY - FOCUS ON PROTEINACEOUS DRUGS

被引：7

|

作者：

STERNSON, LA

机构：

来源：

TRAC-TRENDS IN ANALYTICAL CHEMISTRY | 1989年 / 8卷 / 02期

关键词：

D O I：

10.1016/0165-9936(89)87014-1

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

引用

收藏

页码：43 / 45

页数：3

相关论文

共 50 条

[31] PROBLEMS OF PHARMACEUTICAL-INDUSTRY DEVELOPMENT IN POLAND
SZELEJEWSKI, W
[J]. PRZEMYSL CHEMICZNY, 1985, 64 (10): : 454 - 458
[32] DRUG DISCOVERY AND DEVELOPMENT IN THE PHARMACEUTICAL-INDUSTRY
SCHACTER, LP
ANDERSON, C
CANETTA, RM
KELLEY, S
NICAISE, C
ONETTO, N
ROZENCWEIG, M
SMALDONE, L
WINOGRAD, B
[J]. SEMINARS IN ONCOLOGY, 1992, 19 (06) : 613 - 621
[33] ANALYTICAL CHALLENGES TO THE PHARMACEUTICAL-INDUSTRY IN DEVELOPING PRODUCTS OF BIOTECHNOLOGY
DICKEN, CM
STERNSON, LA
[J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1989, 7 (09) : 1071 - 1076
[34] DETERMINANTS OF THE FOREIGN RESEARCH-AND-DEVELOPMENT LOCATIONAL DECISION IN THE PHARMACEUTICAL-INDUSTRY
TAGGART, JH
[J]. R & D MANAGEMENT, 1991, 21 (03) : 229 - 240
[35] COOPERATION BETWEEN RESEARCH-AND-DEVELOPMENT, MARKETING AND PRODUCTION IN THE PHARMACEUTICAL-INDUSTRY
WAGER, RE
[J]. CHIMIA, 1990, 44 (05) : 153 - 155
[36] RESEARCH AND DEVELOPMENT OF PREPARATIONS OF THE CZECHOSLOVAK PHARMACEUTICAL-INDUSTRY FOR CONTROL OF THE REPRODUCTION CYCLE
SEVCIK, B
[J]. BIOLOGIZACE A CHEMIZACE ZIVOCISNE VYROBY-VETERINARIA, 1981, 17 (01): : 5 - 10
[37] PROSPECT OF RESEARCH AND DEVELOPMENT OF VETERINARY ANTIBIOTICS AND CHEMOTHERAPEUTICS IN CZECHOSLOVAK PHARMACEUTICAL-INDUSTRY
SEVCIK, B
[J]. BIOLOGIZACE A CHEMIZACE ZIVOCISNE VYROBY-VETERINARIA, 1984, 20 (05): : 397 - 400
[38] ANALYTICAL METHOD VALIDATION AND SYSTEM SUITABILITY IN THE PHARMACEUTICAL-INDUSTRY
WIGGINS, DE
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 114 - ANYL
[39] THE CONTRIBUTION OF THE PHARMACEUTICAL-INDUSTRY TO THE ARTICLES ON THE CLINICAL INVESTIGATION ON DRUGS
LLOPIS, MCC
[J]. MEDICINA CLINICA, 1995, 105 (19): : 758 - 758
[40] RESEARCH-AND-DEVELOPMENT COSTS FOR NEW DRUGS BY THERAPEUTIC CATEGORY - A STUDY OF THE UNITED-STATES PHARMACEUTICAL-INDUSTRY
DIMASI, JA
HANSEN, RW
GRABOWSKI, HG
LASAGNA, L
[J]. PHARMACOECONOMICS, 1995, 7 (02) : 152 - 169

← 1 2 3 4 5 →